9 related news articles for Hormone Cancer Therapeutics

Two unique Hudson Institute research projects have been chosen among eight nationally to share in the largest-ever funding distribution from the Ovarian Cancer Research Foundation (OCRF), offering hope to women everywhere.…  Read more

For Associate Professor Simon Chu, the problem leading Hudson Institute’s research into rare ovarian cancers was getting access to large quantities of real-world data, and the solution came from a surprising place: social media.…  Read more

Jessica Clark calls herself the luckiest unlucky person in the world – but she still wants to know why she got ovarian cancer at such a young age.…  Read more

When it comes to rare forms of cancer, researchers and patients share the same problem – finding enough information from which to make informed decisions.…  Read more

Ovarian cancer specialists have taken a novel path to advance their research – tapping into an international Facebook group to learn from members’ experiences.…  Read more

Not even Covid-19 could stop a pioneer in the fight against rare ovarian cancers finishing his epic fundraising ride. In early May Dr Simon Chu took a break from the lab and put rubber on the road in the Ride4Research, aiming to cover 900km in 9 days from Canberra to Melbourne.…  Read more

A pioneer in the fight against rare ovarian cancers is taking a break from the lab and putting rubber on the road as part of the Ride4Research.…  Read more

A double-barrelled, non-surgical method to treat a rare type of ovarian cancer may provide hope for many patients.…  Read more

A new study has identified a genetic mutation that could be linked to an aggressive type of ovarian cancer driven by hormones. A team of scientists at Hudson Institute of Medical Research, with collaborators at the Peter MacCallum Cancer Centre and the University of Western Australia, used large-scale genome sequencing to map the tumour genome…  Read more